Functionality and Accuracy of the smARTrack System in Real-Life ICU Settings
1 other identifier
interventional
20
1 country
1
Brief Summary
This study conducted in order to validate the functionality and accuracy of the smARTrack™ System in a real-life ICU setting. The smARTrack™ Feeding Tube System is a novel system with nasogastric tube developed by ART Healthcare Ltd, based on sensor-lined tubes that transmit real-time information to an external console. The smARTrack™ feeding tube is equipped with reflux sensors which alert when gastric contents regurgitating into the esophagus. In addition, the smARTrack™ feeding tube is equipped with sensors designed to provide information about the location of the tube thus assisting in reducing the incident of misplacement during first positioning. The smARTrack™ feeding tube is also automatically and in real-time stops feeding if the feeding tube moves out of position during ongoing use or detect gastric content in esophagus. Furthermore, smARTrack™ Feeding Tube System can guide operator to correctly re-position the tube.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2016
CompletedFirst Posted
Study publicly available on registry
March 11, 2016
CompletedStudy Start
First participant enrolled
March 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 14, 2018
CompletedSeptember 22, 2020
September 1, 2020
1.6 years
February 9, 2016
September 21, 2020
Conditions
Outcome Measures
Primary Outcomes (5)
System accurately guides correct initial placement
The system is able to accurately guide the user to ensure correct initial placement (verified by X-ray)
24-72 hours
System accurately detects tube movement/displacement during ongoing use
The system is able to detect tube movement/displacement during ongoing use (verified by markings on the tube)
24-72 hours
System automatically stops feeding when displacement is detected
The system automatically stops feeding when tube displacement is detected
24-72 hours
System is able to detect overfeeding
The system is able to detect overfeeding
24-72 hours
Occurrence of device related Adverse Events (Safety)
Occurrence of device related adverse events
24-72 hours
Secondary Outcomes (5)
The system user interface is easy for use
24-72 hours
Correlation of impedance detected to patient positioning
24-72 hours
Quantification of the amount of discarded nutritional supplement by implementing GRV test
24-72 hours
Aspiration of gastric contents percentage compared to standard feeding (as reported in literature)
24-72 hours
Correlation between patient clinical information and the occurrence of reflux and sensors data
24-72 hours
Study Arms (1)
General
EXPERIMENTALOne arm study: smARTrack Feeding Tube System.
Interventions
Eligibility Criteria
You may qualify if:
- Males and females 18 years or older
- Patient has already been admitted to ICU
- Patient requires enteral feeding
- Patients receiving PPI therapy
- Informed consent by independent physician and next of kin
- ICU ventilated patients
You may not qualify if:
- Patients with anomalies or diseases of the nose, throat, or esophagus and or stomach.
- Patients with known sensitivities or allergies to any of the feeding tube materials
- Inability to place patient is semi-Fowler's position.
- Any clinically significant abnormality upon physical examination which may, in the opinion of the investigator, pose difficulty in inserting the feeding tube (e.g. cervical spine disorder)
- Pregnancy
- Recent abdominal surgery (less than 30 days)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ART Medical Ltd.lead
Study Sites (1)
Rambam Health Care Campus
Haifa, 31096, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2016
First Posted
March 11, 2016
Study Start
March 23, 2016
Primary Completion
November 8, 2017
Study Completion
August 14, 2018
Last Updated
September 22, 2020
Record last verified: 2020-09